Robert Andreata‐Santos

791 total citations
30 papers, 242 citations indexed

About

Robert Andreata‐Santos is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Robert Andreata‐Santos has authored 30 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 16 papers in Public Health, Environmental and Occupational Health and 6 papers in Epidemiology. Recurrent topics in Robert Andreata‐Santos's work include Mosquito-borne diseases and control (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Viral Infections and Vectors (9 papers). Robert Andreata‐Santos is often cited by papers focused on Mosquito-borne diseases and control (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Viral Infections and Vectors (9 papers). Robert Andreata‐Santos collaborates with scholars based in Brazil, United States and United Kingdom. Robert Andreata‐Santos's co-authors include Lennon Ramos Pereira, Rúbens Prince dos Santos Alves, Luís Carlos de Souza Ferreira, Edison Luíz Durigon, Viviane Maimoni Gonçalves, Camila Malta Romano, Luciana C. C. Leite, Jaime Henrique Amorim, Luís Carlos de Souza Ferreira and Paolo Marinho de Andrade Zanotto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Virology.

In The Last Decade

Robert Andreata‐Santos

27 papers receiving 240 citations

Peers

Countries citing papers authored by Robert Andreata‐Santos

Since Specialization

Citations

This map shows the geographic impact of Robert Andreata‐Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Andreata‐Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Andreata‐Santos more than expected).

Fields of papers citing papers by Robert Andreata‐Santos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Andreata‐Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Andreata‐Santos. The network helps show where Robert Andreata‐Santos may publish in the future.

Co-authorship network of co-authors of Robert Andreata‐Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Andreata‐Santos. A scholar is included among the top collaborators of Robert Andreata‐Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Andreata‐Santos. Robert Andreata‐Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amino Compound-Synthesized Gold Nanoparticles for SARS-CoV-2 Antigen Delivery 2025 ·Pharmaceutics ·(unknown), Marianna Teixeira de Pinho Favaro, (unknown), Robert Andreata‐Santos, (unknown), Marcelo Martins Seckler, Luís Carlos de Souza Ferreira, Adriano Rodrigues Azzoni	0
2	Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants 2025 ·Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Robert Andreata‐Santos, Ana Iochabel Soares Moretti, (unknown), (unknown), (unknown), (unknown), Márcio Yamamoto, Luís Carlos de Souza Ferreira, Keity Souza Santos, Verônica Coelho, Jorge Kalil, Daniela Santoro Rosa, Edécio Cunha‐Neto, Silvia Beatriz Boscardin	0
3	Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil 2024 ·Journal of Medical Virology ·(unknown), Rafael Rahal Guaragna Machado, (unknown), Robert Andreata‐Santos, (unknown), (unknown), Milena Silva Souza, (unknown), Camila Malta Romano, Edison Luíz Durigon, Jaime Henrique Amorim, Luís Carlos de Souza Ferreira	1
4	Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination 2024 ·Cell Reports ·Jordan J Clark, Irene Hoxie, Daniel C. Adelsberg, (unknown), Robert Andreata‐Santos, (unknown), Fatima Amanat, Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Irene González‐Domínguez, (unknown), Stylianos Bournazos, Weina Sun, Juan Manuel Carreño, Viviana Simon, Ali H. Ellebedy, Goran Bajic, Florian Krammer	11
5	The Relationship between HERV, Interleukin, and Transcription Factor Expression in ZIKV Infected versus Uninfected Trophoblastic Cells 2024 ·Cells ·(unknown), (unknown), (unknown), Robert Andreata‐Santos, (unknown), (unknown), Fernando Antoneli, Ricardo Durães‐Carvalho, Marcelo R. S. Briones, Juliana Terzi Maricato, Paolo Marinho de Andrade Zanotto, Denis Jacob Machado, Luiz Mário Janini	1
6	Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1 2024 ·SHILAP Revista de lepidopterología ·Stephanie K. Lathrop, Jordan J Clark, Karthik Siram, Robert Andreata‐Santos, (unknown), (unknown), (unknown), (unknown), David J. Burkhart, Florian Krammer, Jay T. Evans	1
7	Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS‐CoV‐2 neutralization 2024 ·Immunity Inflammation and Disease ·(unknown), João Paulo Silva Nunes, Daniela Santoro Rosa, Rodrigo da Silva Ferreira, Maria Luiza Vilela Oliva, Robert Andreata‐Santos, (unknown), Luiz Mário Janini, Juliana Terzi Maricato, (unknown), Paulo Lee Ho, Sérgio Schenkman	1
8	Multi-epitope Antigen for Specific Serological Detection of Dengue Viruses 2023 ·Viruses ·(unknown), Robert Andreata‐Santos, Maria Fernanda de Castro‐Amarante, (unknown), (unknown), (unknown), Rúbens Prince dos Santos Alves, (unknown), Luís Carlos de Souza Ferreira	1
9	SARS-CoV-2 Nanovaccine Composed of Microfluidic-Produced Gold Nanoparticles Induces Neutralizing Immune Responses 2023 ·ACS Applied Nano Materials ·(unknown), (unknown), Robert Andreata‐Santos, (unknown), Aline Furtado Oliveira, Adriano Rodrigues Azzoni, Luís Carlos de Souza Ferreira, Marianna Teixeira de Pinho Favaro	6
10	Proposal of Model for Evaluation of Viral Kinetics of African/Asian/Brazilian—Zika virus Strains (Step Growth Curve) in Trophoblastic Cell Lines 2023 ·Viruses ·(unknown), (unknown), (unknown), Robert Andreata‐Santos, (unknown), Paolo Marinho de Andrade Zanotto, Luiz Mário Janini	1
11	SARS-CoV-2 Spike protein peptides displayed in the Pyrococcus furiosus RAD system preserve epitopes antigenicity, immunogenicity, and virus-neutralizing activity of antibodies 2023 ·Scientific Reports ·(unknown), Maria Fernanda de Castro‐Amarante, Aleksei Lulla, Robert Andreata‐Santos, Mário Costa Cruz, Ana Carolina Ramos Moreno, (unknown), (unknown), Lúcio H. Freitas-Júnior, Carolina Borsoi Moraes, Edison Luíz Durigon, (unknown), Marko Hyvönen, Luís Carlos de Souza Ferreira, Andrea Balan	1
12	Lactobacillus rhamnosus Restores Antiviral Signaling and Attenuates Cytokines Secretion from Human Bronchial Epithelial Cells Exposed to Cigarette Smoke and Infected with SARS-CoV-2 2022 ·Probiotics and Antimicrobial Proteins ·(unknown), Robert Andreata‐Santos, (unknown), (unknown), Carlos Rocha Oliveira, Flávio Aimbire	12
13	Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil 2022 ·Frontiers in Cellular and Infection Microbiology ·Robert Andreata‐Santos, Rafael Rahal Guaragna Machado, Rúbens Prince dos Santos Alves, (unknown), Camila Pereira Soares, (unknown), (unknown), Marianna Teixeira de Pinho Favaro, (unknown), Márcio Yamamoto, (unknown), Ricardo Ambrósio Fock, (unknown), (unknown), Silvia Beatriz Boscardin, Edison Luíz Durigon, Luís Carlos de Souza Ferreira	4
14	Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation 2022 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Marianna Teixeira de Pinho Favaro, (unknown), Maria Fernanda de Castro‐Amarante, (unknown), (unknown), Robert Andreata‐Santos, (unknown), (unknown), Lúcio H. Freitas-Júnior, Silvia Beatriz Boscardin, Luís Carlos de Souza Ferreira	5
15	NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus 2021 ·International Journal of Infectious Diseases ·(unknown), Robert Andreata‐Santos, Lennon Ramos Pereira, Camila Pereira Soares, Alvina Clara Félix, (unknown), Edison Luíz Durigon, Camila Malta Romano, Luís Carlos de Souza Ferreira	18
16	Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies 2021 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Marianna Teixeira de Pinho Favaro, Lennon Ramos Pereira, (unknown), (unknown), Robert Andreata‐Santos, Rúbens Prince dos Santos Alves, Maria Fernanda de Castro‐Amarante, (unknown), Jamile Ramos da Silva, Rafael Rahal Guaragna Machado, Marielton dos Passos Cunha, Paolo Marinho de Andrade Zanotto, Wesley Luzetti Fotoran, Gerhard Wunderlich, Edison Luíz Durigon, Luís Carlos de Souza Ferreira	7
17	Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein 2020 ·International Journal of Infectious Diseases ·Robert Andreata‐Santos, (unknown), Lennon Ramos Pereira, Alvina Clara Félix, Camila Malta Romano, Luís Carlos de Souza Ferreira	10
18	Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus 2020 ·Nanomedicine Nanotechnology Biology and Medicine ·Marianna Teixeira de Pinho Favaro, (unknown), (unknown), Rúbens Prince dos Santos Alves, Lennon Ramos Pereira, (unknown), Robert Andreata‐Santos, Luís Carlos de Souza Ferreira	9
19	Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of Response Surface Methodology 2019 ·AMB Express ·(unknown), Luciana C. C. Leite, Lennon Ramos Pereira, (unknown), Robert Andreata‐Santos, Rúbens Prince dos Santos Alves, Edison Luíz Durigon, Luís Carlos de Souza Ferreira, Viviane Maimoni Gonçalves	63
20	Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis model 2015 ·Virology ·Jaime Henrique Amorim, Rúbens Prince dos Santos Alves, (unknown), (unknown), Lennon Ramos Pereira, (unknown), Robert Andreata‐Santos, Camila Malta Romano, Luís Carlos de Souza Ferreira	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact